A recent study demonstrates that Nod2, in a colorectal cancer model, induces activation of NF-κB and MAPKs during the early stages of tumorigenesis, yet suppresses TLR-mediated activation of these signaling molecules during the later stages23. This evidence concerns the gene NOD2 and colorectal cancer.